LOGIN  |  REGISTER
Astria Therapeutics

Mobile-health Network Solutions Announces Participation in the LD Micro Main Event XVII

October 15, 2024 | Last Trade: US$0.27 0.0034 -1.23
  • Presentation on Tuesday, October 29th at 12:30 PM PT

Singapore, Singapore--(Newsfile Corp. - October 15, 2024) - Mobile-health Network Solutions (NASDAQ: MNDR), a leading Asia-Pacific telehealth provider, announced today that it will be presenting at the 17th annual Main Event on Tuesday, October 29th at 12:30 PM PT at the Luxe Sunset Boulevard Hotel. Dr. Tung Yeng Siaw and Dr. Rachel Teoh, Co-Founders and Co-CEOs, will be representing the company.

Chris Lahiji, Founder of LD Micro, shared, "We understand the significance of this event for our industry and the enthusiasm it generates among attendees. We're grateful to the leaders at our parent company, Freedom, for their strong alignment with our vision. Our conference is more than just meetings and presentations—it's about laying the groundwork for the future and establishing it as the essential event in small and micro-cap that no one can miss. I'm truly honored to welcome our valued friends and partners to the seventeenth edition of the Main Event."

Learn more about how Mobile-health Network Solutions is revolutionizing healthcare consumption and delivery with its proprietary health operating system.

Event: LD Micro Main Event XVII
Date: Tuesday, October 29th
Time: 12:30 PM PT

Register to watch the virtual presentation here.

Summary of LD Micro Main Event XVII

The 2024 LD Micro Main Event XVII will run from October 28th to the 30th at the Luxe Sunset Boulevard Hotel in Los Angeles.

Registration will begin at 3:00 PM PT on the 28th followed by keynotes and happy hour.

Presentations will run from 8:00 AM PT - 5:00 PM PT on the 29th and 30th.

This three-day event will feature around 150 companies, presenting in half-hour increments, and attending private meetings with investors.

About Mobile-health Network Solutions

Ranked #41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, we are the first telehealth provider from the Asia-Pacific region to be listed in the US. Through our MaNaDr platform, we offer personalized and reliable medical attention to users worldwide. Our platform allows our community of healthcare providers to have a broader reach to users through virtual clinics without any start-up costs and the ability to connect to a global network of peer-to-peer support groups and partners. Our range of seamless and hassle-free telehealth solutions includes teleconsultation services, prescription fulfillment and other personalized services such as weight management programs and gender-specific care. For more information, please visit https://investors.manadr.com/.

About LD Micro

LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Through the LD Micro Index and annual investor conferences, LD has served as an invaluable asset to all those interested in discovering the next generation of great companies. For more information on LD Micro, visit www.ldmicro.com.

To present or register, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

For further information on Mobile-health Network Solutions:

Mobile-health Network Solutions
Lan Kangming
+65 6222 5223
This email address is being protected from spambots. You need JavaScript enabled to view it.
https://investors.manadr.com/

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB